Optimization of osmotic blood-brain barrier opening to enable intravital microscopy studies on drug delivery in mouse cortex

Chengyan Chu, Anna Jablonska, Wojciech G. Lesniak, Aline M. Thomas, Xiaoyan Lan, Raleigh M. Linville, Shen Li, Peter C. Searson, Guanshu Liu, Monica Pearl, Martin G. Pomper, Miroslaw Janowski, Tim Magnus, Piotr Walczak

Research output: Contribution to journalArticle

Abstract

Intra-arterial (IA) infusion of mannitol induces osmotic blood-brain barrier opening (OBBBO) and that method has been used for decades to improve drug delivery to the brain. However, high variability of outcomes prevented vast clinical adoption. Studies on dynamic multi-scale imaging of OBBBO as well as extravasation of IA injected therapeutic agents are essential to develop strategies assuring precision and reproducibility of drug delivery. Intravital microscopy is increasingly used to capture the dynamics of biological processes at the molecular level in convenient mouse models. However, until now OBBBO has been achieved safely in subcortical structures, which prevented direct insight into the process of extravasation through the skull window. Here, we used our previously developed real-time MRI to adjust the procedure to achieve robust cortical OBBBO. We found that catheter-mediated delivery to the cortex from the ipsilateral carotid artery can be improved by temporarily occluding the contralateral carotid artery. The reproducibility and safety of the method were validated by MRI and histology. This experimental platform was further exploited for studying with intravital microscopy the extravasation of 0.58 kDa rhodamine and 153 kDa anti-VEGF monoclonal antibody (bevacizumab) upon IA injection. Dynamic imaging during IA infusion captured the spatiotemporal dynamic of infiltration for each molecule into the brain parenchyma upon OBBBO. Small-sized rhodamine exhibited faster and higher penetration than the antibody. Histological analysis showed some uptake of the monoclonal antibody after IA delivery, and OBBBO significantly amplified the extent of its uptake. For quantitative assessment of cortical uptake, bevacizumab was radiolabeled with zirconium-89 and infused intraarterially. As expected, OBBBO potentiated brain accumulation, providing 33.90 ± 9.06% of injected dose per gram of brain tissue (%ID/g) in the cortex and 17.09 ± 7.22%ID/g in subcortical structures. In contrast IA infusion with an intact BBB resulted in 3.56 ± 1.06%ID/g and 3.57 ± 0.59%ID/g in the same brain regions, respectively. This study established reproducible cortical OBBBO in mice, which enabled multi-photon microscopy studies on OBBBO and drug targeting. This approach helped demonstrate in a dynamic fashion extravasation of fluorescently-tagged antibodies and their effective delivery into the brain across an osmotically opened BBB.

Original languageEnglish (US)
Pages (from-to)312-321
Number of pages10
JournalJournal of Controlled Release
Volume317
DOIs
StatePublished - Jan 10 2020

Fingerprint

Blood-Brain Barrier
Pharmaceutical Preparations
Intra Arterial Infusions
Brain
Rhodamines
Carotid Arteries
Monoclonal Antibodies
Intra-Arterial Injections
Biological Phenomena
Intravital Microscopy
Antibodies
Mannitol
Drug Delivery Systems
Photons
Skull
Vascular Endothelial Growth Factor A
Microscopy
Histology
Catheters
Safety

Keywords

  • Blood-brain barrier
  • Cortex
  • Intra-arterial
  • Mannitol
  • Two-photon microscopy

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Optimization of osmotic blood-brain barrier opening to enable intravital microscopy studies on drug delivery in mouse cortex. / Chu, Chengyan; Jablonska, Anna; Lesniak, Wojciech G.; Thomas, Aline M.; Lan, Xiaoyan; Linville, Raleigh M.; Li, Shen; Searson, Peter C.; Liu, Guanshu; Pearl, Monica; Pomper, Martin G.; Janowski, Miroslaw; Magnus, Tim; Walczak, Piotr.

In: Journal of Controlled Release, Vol. 317, 10.01.2020, p. 312-321.

Research output: Contribution to journalArticle

Chu, C, Jablonska, A, Lesniak, WG, Thomas, AM, Lan, X, Linville, RM, Li, S, Searson, PC, Liu, G, Pearl, M, Pomper, MG, Janowski, M, Magnus, T & Walczak, P 2020, 'Optimization of osmotic blood-brain barrier opening to enable intravital microscopy studies on drug delivery in mouse cortex', Journal of Controlled Release, vol. 317, pp. 312-321. https://doi.org/10.1016/j.jconrel.2019.11.019
Chu, Chengyan ; Jablonska, Anna ; Lesniak, Wojciech G. ; Thomas, Aline M. ; Lan, Xiaoyan ; Linville, Raleigh M. ; Li, Shen ; Searson, Peter C. ; Liu, Guanshu ; Pearl, Monica ; Pomper, Martin G. ; Janowski, Miroslaw ; Magnus, Tim ; Walczak, Piotr. / Optimization of osmotic blood-brain barrier opening to enable intravital microscopy studies on drug delivery in mouse cortex. In: Journal of Controlled Release. 2020 ; Vol. 317. pp. 312-321.
@article{2b65ad05a9de4ac4818e26dab6acd9d5,
title = "Optimization of osmotic blood-brain barrier opening to enable intravital microscopy studies on drug delivery in mouse cortex",
abstract = "Intra-arterial (IA) infusion of mannitol induces osmotic blood-brain barrier opening (OBBBO) and that method has been used for decades to improve drug delivery to the brain. However, high variability of outcomes prevented vast clinical adoption. Studies on dynamic multi-scale imaging of OBBBO as well as extravasation of IA injected therapeutic agents are essential to develop strategies assuring precision and reproducibility of drug delivery. Intravital microscopy is increasingly used to capture the dynamics of biological processes at the molecular level in convenient mouse models. However, until now OBBBO has been achieved safely in subcortical structures, which prevented direct insight into the process of extravasation through the skull window. Here, we used our previously developed real-time MRI to adjust the procedure to achieve robust cortical OBBBO. We found that catheter-mediated delivery to the cortex from the ipsilateral carotid artery can be improved by temporarily occluding the contralateral carotid artery. The reproducibility and safety of the method were validated by MRI and histology. This experimental platform was further exploited for studying with intravital microscopy the extravasation of 0.58 kDa rhodamine and 153 kDa anti-VEGF monoclonal antibody (bevacizumab) upon IA injection. Dynamic imaging during IA infusion captured the spatiotemporal dynamic of infiltration for each molecule into the brain parenchyma upon OBBBO. Small-sized rhodamine exhibited faster and higher penetration than the antibody. Histological analysis showed some uptake of the monoclonal antibody after IA delivery, and OBBBO significantly amplified the extent of its uptake. For quantitative assessment of cortical uptake, bevacizumab was radiolabeled with zirconium-89 and infused intraarterially. As expected, OBBBO potentiated brain accumulation, providing 33.90 ± 9.06{\%} of injected dose per gram of brain tissue ({\%}ID/g) in the cortex and 17.09 ± 7.22{\%}ID/g in subcortical structures. In contrast IA infusion with an intact BBB resulted in 3.56 ± 1.06{\%}ID/g and 3.57 ± 0.59{\%}ID/g in the same brain regions, respectively. This study established reproducible cortical OBBBO in mice, which enabled multi-photon microscopy studies on OBBBO and drug targeting. This approach helped demonstrate in a dynamic fashion extravasation of fluorescently-tagged antibodies and their effective delivery into the brain across an osmotically opened BBB.",
keywords = "Blood-brain barrier, Cortex, Intra-arterial, Mannitol, Two-photon microscopy",
author = "Chengyan Chu and Anna Jablonska and Lesniak, {Wojciech G.} and Thomas, {Aline M.} and Xiaoyan Lan and Linville, {Raleigh M.} and Shen Li and Searson, {Peter C.} and Guanshu Liu and Monica Pearl and Pomper, {Martin G.} and Miroslaw Janowski and Tim Magnus and Piotr Walczak",
year = "2020",
month = "1",
day = "10",
doi = "10.1016/j.jconrel.2019.11.019",
language = "English (US)",
volume = "317",
pages = "312--321",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",

}

TY - JOUR

T1 - Optimization of osmotic blood-brain barrier opening to enable intravital microscopy studies on drug delivery in mouse cortex

AU - Chu, Chengyan

AU - Jablonska, Anna

AU - Lesniak, Wojciech G.

AU - Thomas, Aline M.

AU - Lan, Xiaoyan

AU - Linville, Raleigh M.

AU - Li, Shen

AU - Searson, Peter C.

AU - Liu, Guanshu

AU - Pearl, Monica

AU - Pomper, Martin G.

AU - Janowski, Miroslaw

AU - Magnus, Tim

AU - Walczak, Piotr

PY - 2020/1/10

Y1 - 2020/1/10

N2 - Intra-arterial (IA) infusion of mannitol induces osmotic blood-brain barrier opening (OBBBO) and that method has been used for decades to improve drug delivery to the brain. However, high variability of outcomes prevented vast clinical adoption. Studies on dynamic multi-scale imaging of OBBBO as well as extravasation of IA injected therapeutic agents are essential to develop strategies assuring precision and reproducibility of drug delivery. Intravital microscopy is increasingly used to capture the dynamics of biological processes at the molecular level in convenient mouse models. However, until now OBBBO has been achieved safely in subcortical structures, which prevented direct insight into the process of extravasation through the skull window. Here, we used our previously developed real-time MRI to adjust the procedure to achieve robust cortical OBBBO. We found that catheter-mediated delivery to the cortex from the ipsilateral carotid artery can be improved by temporarily occluding the contralateral carotid artery. The reproducibility and safety of the method were validated by MRI and histology. This experimental platform was further exploited for studying with intravital microscopy the extravasation of 0.58 kDa rhodamine and 153 kDa anti-VEGF monoclonal antibody (bevacizumab) upon IA injection. Dynamic imaging during IA infusion captured the spatiotemporal dynamic of infiltration for each molecule into the brain parenchyma upon OBBBO. Small-sized rhodamine exhibited faster and higher penetration than the antibody. Histological analysis showed some uptake of the monoclonal antibody after IA delivery, and OBBBO significantly amplified the extent of its uptake. For quantitative assessment of cortical uptake, bevacizumab was radiolabeled with zirconium-89 and infused intraarterially. As expected, OBBBO potentiated brain accumulation, providing 33.90 ± 9.06% of injected dose per gram of brain tissue (%ID/g) in the cortex and 17.09 ± 7.22%ID/g in subcortical structures. In contrast IA infusion with an intact BBB resulted in 3.56 ± 1.06%ID/g and 3.57 ± 0.59%ID/g in the same brain regions, respectively. This study established reproducible cortical OBBBO in mice, which enabled multi-photon microscopy studies on OBBBO and drug targeting. This approach helped demonstrate in a dynamic fashion extravasation of fluorescently-tagged antibodies and their effective delivery into the brain across an osmotically opened BBB.

AB - Intra-arterial (IA) infusion of mannitol induces osmotic blood-brain barrier opening (OBBBO) and that method has been used for decades to improve drug delivery to the brain. However, high variability of outcomes prevented vast clinical adoption. Studies on dynamic multi-scale imaging of OBBBO as well as extravasation of IA injected therapeutic agents are essential to develop strategies assuring precision and reproducibility of drug delivery. Intravital microscopy is increasingly used to capture the dynamics of biological processes at the molecular level in convenient mouse models. However, until now OBBBO has been achieved safely in subcortical structures, which prevented direct insight into the process of extravasation through the skull window. Here, we used our previously developed real-time MRI to adjust the procedure to achieve robust cortical OBBBO. We found that catheter-mediated delivery to the cortex from the ipsilateral carotid artery can be improved by temporarily occluding the contralateral carotid artery. The reproducibility and safety of the method were validated by MRI and histology. This experimental platform was further exploited for studying with intravital microscopy the extravasation of 0.58 kDa rhodamine and 153 kDa anti-VEGF monoclonal antibody (bevacizumab) upon IA injection. Dynamic imaging during IA infusion captured the spatiotemporal dynamic of infiltration for each molecule into the brain parenchyma upon OBBBO. Small-sized rhodamine exhibited faster and higher penetration than the antibody. Histological analysis showed some uptake of the monoclonal antibody after IA delivery, and OBBBO significantly amplified the extent of its uptake. For quantitative assessment of cortical uptake, bevacizumab was radiolabeled with zirconium-89 and infused intraarterially. As expected, OBBBO potentiated brain accumulation, providing 33.90 ± 9.06% of injected dose per gram of brain tissue (%ID/g) in the cortex and 17.09 ± 7.22%ID/g in subcortical structures. In contrast IA infusion with an intact BBB resulted in 3.56 ± 1.06%ID/g and 3.57 ± 0.59%ID/g in the same brain regions, respectively. This study established reproducible cortical OBBBO in mice, which enabled multi-photon microscopy studies on OBBBO and drug targeting. This approach helped demonstrate in a dynamic fashion extravasation of fluorescently-tagged antibodies and their effective delivery into the brain across an osmotically opened BBB.

KW - Blood-brain barrier

KW - Cortex

KW - Intra-arterial

KW - Mannitol

KW - Two-photon microscopy

UR - http://www.scopus.com/inward/record.url?scp=85075973955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075973955&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2019.11.019

DO - 10.1016/j.jconrel.2019.11.019

M3 - Article

C2 - 31751635

AN - SCOPUS:85075973955

VL - 317

SP - 312

EP - 321

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

ER -